Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) Shorted Shares Increased By 35.48%
by Franklin Staff — May 16, 2016
The stock of Oncogenex Pharmaceuticals Incorporated (NASDAQ:OGXI) registered an increase of 35.48% in short interest. OGXI’s total short interest was 1.16 million shares in May as published by FINRA. Its up 35.48% from 854,600 shares, reported previously. With 1.95 million shares average volume, it will take short sellers 1 days to cover their OGXI’s short positions. The short interest to Oncogenex Pharmaceuticals Incorporated’s float is 3.92%. The stock increased 5.40% or $0.046 on May 16, hitting $0.89. About 197,081 shares traded hands. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has declined 61.64% since October 8, 2015 and is downtrending. It has underperformed by 63.29% the S&P500.
OncoGenex Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm engaged in the development and commercialization of therapies that address treatment resistance in cancer patients. The company has a market cap of $27.09 million. The Company’s segment is dedicated to the development and commercialization of cancer therapies, with activities located in Canada and the United States. It currently has negative earnings. The Company’s product candidates include Custirsen, Apatorsen and OGX-225.
Out of 4 analysts covering OncoGenex Pharma (NASDAQ:OGXI), 2 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 50% are positive. OncoGenex Pharma has been the topic of 6 analyst reports since August 17, 2015 according to StockzIntelligence
http://www.franklinindependent.com/...rted-shares-increased-by-35-48/
|
